Biolexis Therapeutics Launches Pioneering GLP-1 and AMPK Clinical Trials for Metabolic Disease Treatments Biolexis Therapeutics has announced the start of first-in-human clinical trials for their innovative GLP-1 and AMPK programs, showcasing progress in metabolic disease treatment.

Biolexis Therapeutics Launches Pioneering GLP-1 and AMPK Clinical Trials for Metabolic Disease Treatments #USA #GLP-1 #Lehi #Biolexis #AMPK